We provide individualized guidance not a starvation protocol, but a sustainable approach that the appetite suppression of the medication makes genuinely easier to follow
51% female), a sample representing 126 million US adults, in the National Health and Nutrition Examination Survey (NHANES) 2017-2020 database who met clinical inclusion criteria for obesity or overweight plus at least one weight-related comorbidity such as diabetes, hypertension, dyslipidemia, or cardiovascular disease
Lets make your weight loss dreams a reality
Yes, the PlexusDx Precision Peptide Genetic Test identifies variants in your GIPR, FTO, and MC4R genes that influence how you respond to semaglutide and tirzepatide
SGLT2 Inhibitors in Patients with Atrial Fibrillation and HFpEF: A Propensity-Matched Real-World Analysis, Journal of Clinical Medicine, 15 , 13, (4992), (2026)